Granted Patent
B2
US 8,029,787 · App. 12/787,675 · Granted Oct 4, 2011
Method of diagnosing, monitoring, staging, imaging and treating various cancers
Assignee:
diaDexus, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Abstract
The present invention provides a new method for detecting, diagnosing, monitoring, staging, prognosticating, imaging and treating selected cancers including gynecologic cancers such as breast, ovarian, uterine and endometrial cancer and lung cancer.
Claims (2)
1. A method of treating ovarian, uterine, endometrial or breast cancer in a patient comprising administering to the patient an antibody which binds to a protein encoded by polynucleotide sequence SEQ ID NO:1 or a fragment thereof, wherein the fragment of the protein encoded by polynucleotide sequence SEQ ID NO:1 is encoded by polynucleotide sequence SEQ ID NO:12 or SEQ ID NO:13.
2. The method of claim 1 wherein the antibody is conjugated to a cytotoxic agent.
Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Feb 7, 2017
From: GENERAL ATOMICS
To: DIAZYME LABORATORIES, INC.
Reel/Frame 041651/0661 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Jan 4, 2017
From: DIADEXUS, INC.
To: GENERAL ATOMICS
Reel/Frame 041245/0899 →
ASSIGNMENT OF ASSIGNOR'S INTEREST
Recorded Dec 28, 2016
From: SALCEDA, SUSANA; SUN, YONGMING; RECIPON, HERVE; CAFFERKEY, ROBERT
To: DIADEXUS, INC.
Reel/Frame 040791/0719 →
CHANGE OF NAME
Recorded Dec 28, 2016
From: DIADEXUS, INC.
To: DIADEXUS, INC.
Reel/Frame 040791/0732 →
Continuity (3)
Continuation
09763978
Provisional Application
60098880
· Sep 2, 1998